Flex Pharma to Present at the BIO CEO & Investor Conference
February 07 2017 - 1:31PM
Business Wire
Click to Tweet
Flex Pharma, Inc. (NASDAQ: FLKS) today announced that Company
management will present a corporate overview at the 2017 BIO CEO
& Investor Conference on Tuesday, February 14, 2017 at 10:00
a.m.
A live webcast of Flex Pharma’s presentations at these
conferences may be accessed in the Investor section of the
Company’s website at www.flex-pharma.com. Please log on to the Flex
Pharma website approximately 15 minutes prior to the scheduled
webcast to ensure adequate time for any software downloads that may
be required. A replay of the webcast will be available on Flex
Pharma’s website for 2 weeks following each presentation.
About Flex Pharma
Flex Pharma, Inc. is a biotechnology company that is developing
innovative and proprietary treatments for cramps and spasms
associated with the severe neurological diseases of ALS, MS and
peripheral neuropathies such as Charcot-Marie-Tooth (CMT). Flex
Pharma was founded by National Academy of Science members Rod
MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D.,
recognized leaders in the fields of ion channels and neurobiology,
along with Chair and CEO Christoph Westphal, M.D., Ph.D.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170207006296/en/
Flex Pharma, Inc.Elizabeth Woo, 617-874-1829SVP, Investor
Relations & Corporate Communicationsirdept@flex-pharma.com
FLEX PHARMA, INC. (NASDAQ:FLKS)
Historical Stock Chart
From Aug 2024 to Sep 2024
FLEX PHARMA, INC. (NASDAQ:FLKS)
Historical Stock Chart
From Sep 2023 to Sep 2024